Author:
Neeroa Bibi Noorheen Haleema Mooneerah,Anuar Nurshafida Adzlin Shamsul,Brianna ,Yusefi Mostafa,Shameli Kamyar,Teow Sin-Yeang
Publisher
Springer Nature Switzerland
Reference87 articles.
1. AbouAitah K, Hassan HA, Swiderska-Sroda A, Gohar L, Shaker OG, Wojnarowicz J, Opalinska A, Smalc-Koziorowska J, Gierlotka S, Lojkowski W (2020) Targeted nano-drug delivery of colchicine against colon cancer cells by means of mesoporous silica nanoparticles. Cancers 12(1):144. https://doi.org/10.3390/cancers12010144
2. Alkhader E, Roberts CJ, Rosli R, Yuen KH, Seow EK, Lee YZ, Billa N (2018) Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles. J Biomater Sci Polym Ed 29(18):2281–2298. https://doi.org/10.1080/09205063.2018.1541500
3. Awi NJ, Yap HY, Armon S, Low JSH, Peh KB, Peh SC, Lee CS, Teow SY (2021) Association between autophagy and KRAS mutation with clinicopathological variables in colorectal cancer patients. Malays J Pathol 43(2):269–279
4. Babaei M, Abnous K, Taghdisi SM, Taghavi S, Saljooghi AS, Ramezani M, Alibolandi M (2020) Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo. Eur J Pharm Biopharm 156:84–96. https://doi.org/10.1016/J.EJPB.2020.08.026
5. Biller LH, Schrag D (2021) Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA 325(7):669–685. https://doi.org/10.1001/jama.2021.0106